Page last updated: 2024-08-22

methylprednisolone hemisuccinate and Neoplasms

methylprednisolone hemisuccinate has been researched along with Neoplasms in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19904 (50.00)18.7374
1990's2 (25.00)18.2507
2000's2 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grem, JL; Quinn, MG; Schuler, B; Thomas, RR1
GIGNOUX, M; POMMATAU, E; REVILLARD, JP1
Broadwater, G; Chao, NJ; Folz, RJ; Wanko, SO1
Cook, RJ1
Futatsugi, K; Kobayashi, H; Koizumi, W; Komatsu, H; Minato, K; Nakarai, I; Nukariya, N; Taira, O; Uchiyama, T; Yamaguchi, T1
Giongo, F; Lucchi, R; Popiela, T1
Della Cuna, GR; Pellegrini, A; Piazzi, M1
Ruderman, MI; Turkewitz, LJ1

Reviews

1 review(s) available for methylprednisolone hemisuccinate and Neoplasms

ArticleYear
Hypersensitivity and idiosyncratic reactions to oxaliplatin.
    Cancer, 2003, May-01, Volume: 97, Issue:9

    Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents; Antiemetics; Antineoplastic Agents; Cimetidine; Dexamethasone; Diphenhydramine; Drug Hypersensitivity; Dyspnea; Erythema; Female; Fever; Histamine H2 Antagonists; Humans; Male; Methylprednisolone Hemisuccinate; Middle Aged; Neoplasms; Organoplatinum Compounds; Oxaliplatin

2003

Trials

3 trial(s) available for methylprednisolone hemisuccinate and Neoplasms

ArticleYear
[A comparative study of the effect of granisetron and a combination of granisetron plus steroids on cancer chemotherapy induced emesis].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:12

    Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Infusions, Intravenous; Male; Methylprednisolone Hemisuccinate; Middle Aged; Nausea; Neoplasms; Vomiting

1995
Methylprednisolone as palliative therapy for female terminal cancer patients. The Methylprednisolone Female Preterminal Cancer Study Group.
    European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:12

    Topics: Double-Blind Method; Female; Humans; Methylprednisolone; Methylprednisolone Hemisuccinate; Multicenter Studies as Topic; Neoplasms; Palliative Care; Quality of Life; Randomized Controlled Trials as Topic; Terminal Care

1989
Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: a placebo-controlled, multicenter study. The Methylprednisolone Preterminal Cancer Study Group.
    European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Male; Methylprednisolone; Methylprednisolone Hemisuccinate; Middle Aged; Multicenter Studies as Topic; Neoplasms; Quality of Life; Randomized Controlled Trials as Topic

1989

Other Studies

4 other study(ies) available for methylprednisolone hemisuccinate and Neoplasms

ArticleYear
[Value of methyl-6-prednisolone sodium hemisuccinate (Solumedrol) in the treatment of malignant tumors].
    Lyon medical, 1962, Dec-09, Volume: 94

    Topics: Humans; Methylprednisolone; Methylprednisolone Hemisuccinate; Neoplasms; Prednisolone; Sodium; Sodium, Dietary

1962
Diffuse alveolar hemorrhage: retrospective review of clinical outcome in allogeneic transplant recipients treated with aminocaproic acid.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2006, Volume: 12, Issue:9

    Topics: Adult; Aminocaproates; Anti-Inflammatory Agents; Female; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Lung Diseases; Male; Methylprednisolone Hemisuccinate; Middle Aged; Neoplasms; Respiratory Insufficiency; Retrospective Studies; Time Factors

2006
Interim analyses in 2 x 2 crossover trials.
    Biometrics, 1995, Volume: 51, Issue:3

    Topics: Antiemetics; Antineoplastic Agents; Biometry; Clinical Trials as Topic; Cross-Over Studies; Humans; Mathematics; Methylprednisolone Hemisuccinate; Metoclopramide; Nausea; Neoplasms; Randomized Controlled Trials as Topic; Research Design

1995
Current therapy of demyelinating neuropathies.
    The Mount Sinai journal of medicine, New York, 1985, Volume: 52, Issue:6

    Topics: Adrenocorticotropic Hormone; Adult; Charcot-Marie-Tooth Disease; Child; Chronic Disease; Combined Modality Therapy; Demyelinating Diseases; Humans; Immunosuppressive Agents; Methylprednisolone Hemisuccinate; Neoplasms; Nervous System Diseases; Paraproteinemias; Plasmapheresis; Polyradiculoneuropathy; Prednisolone; Prednisone; Respiration, Artificial

1985